This genetic testing bundle identifies mutations in MLH1, MSH2, MSH6, PMS2, and EPCAM genes linked to Lynch syndrome, a hereditary condition elevating risks for colorectal, endometrial, and ovarian cancers. Using next-generation sequencing (NGS), the panel offers precise detection of pathogenic variants. Designed for early intervention, the service enhances cancer prevention through proactive, accessible hereditary cancer care.